Estrogen Receptor Immunocytochemical Assay on Cytologic Material from Primary and Metastatic Breast Cancer

References

• Knight W A, Livingstone R B, Gregory E J, McGuire W L. Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. Cancer Res 1977; 37: 4669–71
   PubMed Web of Science ®Google Scholar
• Beex L VA, Koenders A JM. Is hormonal responsiveness in breast cancer age dependent?. Rev Endocrine Related Cancer 1984; 19: 5–10
   Google Scholar
• Greene G L, Nolan C, Engler J P, Jensen E V. Monoclonal antibodies to human estrogen receptor. Proc Natl Acad Sci USA 1980; 77: 5115–9
   PubMed Web of Science ®Google Scholar
• Bilous A M, Tyler J PP, Toppila M, Milliken J. Whither cytosolic estrogen receptor assays? A comparison of commercially available kits for estrogen receptor assay. Pathology 1987; 19: 223–8
   PubMedGoogle Scholar
• King W J, DeSombre E R, Jensen E V, Greene G L. Comparison of immunocytochemical and steroid-binding assays for estrogen receptor in human breast tumours. Cancer Res 1985; 45: 293–304
   PubMed Web of Science ®Google Scholar
• McCarty K S., Jr, Szabo E, Flowers J L, et al. Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors. Cancer Res 1986; 46(Suppl)4244s–8s
   Google Scholar
• DeSombre E R, Thorpe S M, Rose C, et al. Prognostic usefulness of estrogen receptor immunocytochemical assays for human breast cancer. Cancer Res (Suppl) 1986; 46: 4256s–64s
   Web of Science ®Google Scholar
• Charpin C, Martin P-M., Jacquemier J, et al. Estrogen receptor immunocytochemical assay (ER-ICA): Computerized image analysis system, immunoelectron microscopy, and comparisons with estradiol binding assays in 115 breast carcinomas. Cancer Res (Suppl) 1986; 46: 4271s–7s
   Web of Science ®Google Scholar
• Heubner A, Beck T, Grill H-J., Pollow K. Comparison of immunocytochemical estrogen receptor assay, estrogen receptor enzyme immunoassay and radioligand-labelled estrogen receptor assay in human breast cancer and uterine tissue. Cancer Res (Suppl) 1986; 46: 4291s–5s
   Google Scholar
• Jonat W, Maass H, Stegner H E. Immunohistochemical measurement of estrogen receptors in breast cancer tissue samples. Cancer Res (Suppl) 1986; 46: 4296s–8s
   PubMed Web of Science ®Google Scholar
• Ozzello L, De Rosa C M, Konrath J G, et al. Detection of estrophilin in frozen sections of breast cancers using an estrogen receptor immunocytochemical assay. Cancer Res (Suppl) 1986; 46: 4303s–7s
   Web of Science ®Google Scholar
• Earl M. Cell collection from fine needle aspirates for estrogen receptor immunocytochemical assay. Acta Cytol 1987; 31: 377–8
   PubMedGoogle Scholar
• Smyth C M, Reeve T S. Two aids in estrogen receptor characterization. Aust NZ J Surg 1982; 52: 161–4
   PubMedGoogle Scholar
• Koenders A, Thorpe S M. Standardization of steroid receptor assays in human breast cancer. I, Reproducibility of estradiol and progesterone receptor assays. Eur J Cancer Clin Oncol 1983; 19: 1221–9
   PubMedGoogle Scholar
• Leclercq G, Bojar H, Goussard J, et al. Abbott monoclonal enzyme immunoassay measurement of estrogen receptors in human breast cancer: A European multicenter study. Cancer Res (Suppl) 1986; 46: 4233s–6s
   PubMed Web of Science ®Google Scholar
• Jordan V C, Jacobson H I, Keenan E J. Determination of estrogen receptor in breast cancer using monoclonal antibody technology: Results of a multicenter study in the United States. Cancer Res (Suppl) 1986; 46: 4237s–40s
   Web of Science ®Google Scholar
• Bojar H. Quality control requirements in estrogen receptor determination. Cancer Res (Suppl) 1986; 46: 4249s–50s
   Web of Science ®Google Scholar
• Magdelenat H, Merle S, Zajdela A. Enzyme immunoassay of estrogen receptors in fine needle aspirates of breast tumours. Cancer Res (Suppl) 1986; 46: 4265s–7s
   Web of Science ®Google Scholar
• Di Fronzo G, Miodini P, Brivio M, et al. Comparison of immunochemical and radioligand binding assays for estrogen receptors in human breast tumours. Cancer Res (Suppl) 1986; 46: 4278s–81s
   Web of Science ®Google Scholar
• Goussard J, Lechevrel C, Martin P-M., Roussel G. Comparison of monoclonal antibodies and tritiated ligands for estrogen receptor assays in 241 breast cancer cytosols. Cancer Res (Suppl) 1986; 46: 4282s–7s
   PubMed Web of Science ®Google Scholar
• Nicholson R I, Colin P, Francis A B, et al. Evaluation of an enzyme immunoassay for estrogen receptors in human breast cancers. Cancer Res (Suppl) 1986; 46: 4299s–302s
   PubMed Web of Science ®Google Scholar
• Spona J, Gitsch E, Kubista E, et al. Enzyme immunoassay and Scatchard plot estimation of estrogen receptor in gynecological tumours. Cancer Res (Suppl) 1986; 46: 4310s–2s
   Web of Science ®Google Scholar
• Sternberger L A, Hardy P A., Jr, Cuculis J J, Meyer H G. The unlabelled antibody enzyme method of immunohistochemistry. Preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in the identification of spirochetes. J Histochem Cytochem 1970; 18: 315–33
   PubMed Web of Science ®Google Scholar
• Jarvis L R. A microcomputer system for video image analysis and diagnostic microdensitometry. Analyt Quant Cytol 1986; 8: 201–9
   Google Scholar
• Walpole R E. Introduction to statistics, 2nd ed. Macmillan Publishing Co Inc, New York 1974
   Google Scholar
• Galen R S, Gambino S R. Beyond normality: The predictive value and efficiency of medical diagnoses. John Wiley & Sons, New York 1975
   Google Scholar
• Weintraub J, Weintraub D, Redard M, Vassilakos P. Evaluation of estrogen receptors by immunocytochemistry on fine-needle aspiration biopsy specimens from breast tumours. Cancer 1987; 60: 1163–72
   PubMed Web of Science ®Google Scholar
• Azavedo E, Baral E, Skoog L. Immunohistochemical analysis of estrogen receptors in cells obtained by fine needle aspiration from human mammary carcinomas. Anticancer Res 1986; 6: 263–6
   PubMedGoogle Scholar
• McClelland R A, Berger U, Wilson P, et al. Presurgical determination of estrogen receptor status using immunocytochemically stained fine needle aspirate smears in patients with breast cancer. Cancer Res 1987; 47: 6118–22
   PubMed Web of Science ®Google Scholar
• Flowers J L, Burton G V, Cox E B, et al. Use of monoclonal anti-estrogen receptor antibody to evaluate estrogen receptor content in fine needle aspiration breast biopsies. Ann Surg 1986; 203: 250–4
   PubMed Web of Science ®Google Scholar
• Kern W H. Hormone receptor levels and aspiration cytology in cancer of the breast. Am J Clin Pathol 1982; 78: 847–9
   Google Scholar
• McClelland R A, Berger U, Miller L S, et al. Immunocytochemical assay for estrogen receptor: Relationship to outcome of therapy in patients with advanced breast cancer. Cancer Res (Suppl) 1986; 46: 4241s–3s
   PubMedGoogle Scholar
• Tosi P, Baak J PA, Luzi P, et al. Correlation between immuno-histochemically determined oestrogen receptor content, using monoclonal antibodies, and qualitative and quantitative tissue features in ductal breast cancer. Histopathology 1987; 11: 741–51
   PubMed Web of Science ®Google Scholar
• Coombes R C, Berger U, McClelland R A, et al. Prediction of endocrine response in breast cancer by immunocytochemical detection of oestrogen receptor in fine-needle aspirates. Lancet 1987; 11: 701–3
   Google Scholar
• Reiner A, Spona J, Reiner G, et al. Estrogen receptor analysis on biopsies and fine-needle aspirates from human breast carcinoma. Am J Pathol 1986; 125: 443–9
   PubMed Web of Science ®Google Scholar
• Pertschuk L P, Eisenberg K B, Carter A C, Feldman J G. Heterogeneity of estrogen binding sites in breast cancer: Morphologic demonstration and relationship to endocrine response. Breast Cancer Res Treat 1985; 5: 137–47
   PubMedGoogle Scholar
• Osborne C K. Heterogeneity in hormone receptor status in primary and metastatic breast cancer. Semin Oncol 1985; 12: 317–26
   PubMed Web of Science ®Google Scholar
• Blarney R W. The Nottingham Research Programme in Breast Cancer. Aust NZ J Surg 1984; 54: 191–9
   Google Scholar